Structure and mechanism of the broad spectrum CRISPR-associated ring nuclease Crn4
Haotian ChiiD, Ville HoikkalaiD, Stephen A. McMahoniD, Shirley GrahamiD, T.M. GlosteriD, Malcolm F. WhiteiD
Abstract
Type III CRISPR systems detect the presence of RNA from mobile genetic elements (MGE) in prokaryotes, providing antiviral immunity. On activation, the catalytic Cas10 subunit conjugates ATP to form cyclic oligoadenylate (cOA) signalling molecules that activate ancillary e\ectors, providing an immune response. Cellular ring nucleases degrade cOA to reset the system. Here, we describe the structure and mechanism of a new family of ring nucleases, Crn4, associated with type III-D CRISPR systems. The crystal structure of Crn4 reveals a small homodimeric protein with a fold unrelated to any known ring nuclease or, indeed, any known protein structure. Crn4 degrades a range of cOA species to linear oligoadenylates in vitro and ameliorates type III CRISPR immunity in vivo. Phage and plasmids also encode Crn4 orthologues that may function as anti-CRISPRs. These observations expand our understanding of ring nucleases and reveal a new protein fold for cyclic nucleotide recognition.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 27%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tetramerisation of the CRISPR ring nuclease Csx3 facilitates cyclic oligoadenylate cleavage
S. Graham, S. Grüschow, … J. S. Athukoralage·bioRxiv·Apr 28, 2020
- Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
J. S. Athukoralage, C. Rouillon, … M. F. White·bioRxiv·Jul 30, 2018
- Molecular basis of stepwise cyclic tetra-adenylate cleavage by the type III CRISPR ring nuclease Crn1/Sso2081
Liyang Du, Danping Zhang, … Zhonghui Lin·Nucleic Acids ResearchPeer-reviewed·Feb 4, 2023
- Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
S. A. McMahon, W. Zhu, … T. M. Gloster·bioRxiv·Sep 26, 2019
- The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling
J. S. Athukoralage, S. Grüschow, … M. F. White·bioRxiv·Feb 12, 2020
- Fuse to defuse: a self-limiting ribonuclease-ring nuclease fusion for type III CRISPR defence
A. Samolygo, J. S. Athukoralage, … M. F. White·bioRxiv·Mar 11, 2020